Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Major shifts in clinical practice rarely evolve as quickly or dramatically as has occurred with the practice of offering a trial of labor to patients who have had a previous cesarean section. Vaginal birth after cesarean (VBAC) has become a relatively rare event in recent years. The popular press has addressed the issue as a matter of patient choice, while the obstetrical community has focused on safety – both for the patient and for the health care providers. Medical malpractice liability has been cited as a reason for the decision by a number of hospitals in the United States to stop offering VBAC to its patients. If that is, in fact, one of the reasons for this move, it demonstrates the essential nature of our legal system as a check on the use of dangerous and unsupported clinical practices by our health care community.
VBAC in Recent History
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.